“Jeremy Curnock-Cook, the world-famous name in the field of Biotechnology, was our guest – evaluating developments and investment opportunities in the field of new-generation technology.” From Erdem Erkul, CEO of Cerebrum Technologies, and Chairperson of Digital Technologies Business Council of DEIK. LinkedIn post Caner Çolak, Secretary General of DEIK Erdem Erkul, CEO of Cerebrum Technologies […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2024-01-24 03:40:192024-02-14 01:05:41Jeremy in Türkiye as a guest at the Foreign Economic Relations Board (DEIK)
Link Here Minneapolis, Minnesota – December 14, 2023 – Saluda Medical, Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies, today announced the appointment of Jim Erickson as Chief Financial Officer (CFO). “I am thrilled to welcome Jim to Saluda and believe his […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-12-19 05:02:082023-12-19 05:04:06Saluda Medical Appoints Jim Erickson as Chief Financial Officer
Link Here Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote patient monitoring and data management solutions, is pleased to announce that it has commenced production and market release of the new, next generation Hailie® sensors with physiological parameters connecting GlaxoSmithKline (GSK) Ventolin®, Advair®/Flixotide® and Flovent®/Seretide® inhalers for monitoring Asthma […]
Initiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, Sept. 26, 2023 /Link here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-10-02 06:32:372023-10-02 06:32:37Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
Initiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, /Link Here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-09-28 01:24:072023-09-28 01:25:29Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
LA JOLLA, Calif., Sept. 6, 2023 /Link here/ — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 25th […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-09-11 01:16:242023-09-11 01:16:24CalciMedica Announces Upcoming Presentations and Events in September
LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ Link here — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-09-05 23:40:172023-09-05 23:40:17CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies May 03, 2023 08:30 ET| Source: Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been selected as the winner of the […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-08-07 01:03:432023-08-07 01:03:43Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
Melbourne, Australia; Link here – 27 July 2023: Adherium Limited (ASX: ADR), a leading provider of respiratory eHealth, remote monitoring and data management solutions, today announced it is entering a rapid commercialisation phase in reimbursed remote patient monitoring in the globally significant US market. Adherium’s leading position in remote patient monitoring, using the Hailie® app […]
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies VANCOUVER, British Columbia; Link here – May 3, 2023 – Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-05-29 04:51:082023-05-29 04:51:08Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
Jeremy in Türkiye as a guest at the Foreign Economic Relations Board (DEIK)
/in BioSciences Managers, Industry News, Uncategorised“Jeremy Curnock-Cook, the world-famous name in the field of Biotechnology, was our guest – evaluating developments and investment opportunities in the field of new-generation technology.” From Erdem Erkul, CEO of Cerebrum Technologies, and Chairperson of Digital Technologies Business Council of DEIK. LinkedIn post Caner Çolak, Secretary General of DEIK Erdem Erkul, CEO of Cerebrum Technologies […]
Saluda Medical Appoints Jim Erickson as Chief Financial Officer
/in BioSciences Managers, Saluda MedicalLink Here Minneapolis, Minnesota – December 14, 2023 – Saluda Medical, Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies, today announced the appointment of Jim Erickson as Chief Financial Officer (CFO). “I am thrilled to welcome Jim to Saluda and believe his […]
Adherium announces production & market release of new, next-gen sensors
/in Adherium, UncategorisedLink Here Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote patient monitoring and data management solutions, is pleased to announce that it has commenced production and market release of the new, next generation Hailie® sensors with physiological parameters connecting GlaxoSmithKline (GSK) Ventolin®, Advair®/Flixotide® and Flovent®/Seretide® inhalers for monitoring Asthma […]
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
/in Armata PharmaceuticalsInitiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, Sept. 26, 2023 /Link here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for […]
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
/in Armata Pharmaceuticals, UncategorisedInitiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, /Link Here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and […]
CalciMedica Announces Upcoming Presentations and Events in September
/in CalcimedicaLA JOLLA, Calif., Sept. 6, 2023 /Link here/ — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny, Ph.D., Chief Executive Officer, will participate in a presentation at the H.C. Wainwright 25th […]
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
/in CalcimedicaLA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ Link here — CalciMedica Inc. (“CalciMedica”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it will host a virtual clinical experts event on Thursday, September 21, 2023, from 10:30 […]
Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
/in Canary MedicalPrestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies May 03, 2023 08:30 ET| Source: Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been selected as the winner of the […]
SHAREHOLDER UPDATE: ADHERIUM ENTERS RAPID US COMMERCIALISATION PHASE
/in AdheriumMelbourne, Australia; Link here – 27 July 2023: Adherium Limited (ASX: ADR), a leading provider of respiratory eHealth, remote monitoring and data management solutions, today announced it is entering a rapid commercialisation phase in reimbursed remote patient monitoring in the globally significant US market. Adherium’s leading position in remote patient monitoring, using the Hailie® app […]
Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
/in Canary MedicalPrestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies VANCOUVER, British Columbia; Link here – May 3, 2023 – Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been […]